United States · FDA National Drug Code directory

phenytoin sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62756-299_c89dfc75-606c-4a4e-9d2b-d907b492a837
Product NDC
62756-299
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
phenytoin sodium
Labeler
Sun Pharmaceutical Industries, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20080630
Source listing expiry
20261231

Source-listed ingredients

  • PHENYTOIN SODIUM — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-08) · 62756-299-08
  • 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-13) · 62756-299-13
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-83) · 62756-299-83
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-88) · 62756-299-88

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
phenytoin sodium — United States | Molindra Medicines